About Agrawal Medicaments Private Limited
Data last updated:
Agrawal Medicaments Private Limited is a private limited company based in Margao, Goa, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24119GA2012PTC007117. Its GSTIN is 30AALCA7314F1Z3 (Goa). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Krishnakumar Gangadhar Agrawal and Anirudh Krishnakumar Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Anand Bhavan Old Station Road, Margao, Goa, India – 403601.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.64 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹11.97 Lakh (net margin -71.9%) and EBITDA of -₹11.91 Lakh (EBITDA margin -71.6%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 29% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website agrawalgroupgoa.com.
Company details
Contact details
Agrawal Medicaments Private Limited's registered office is in Margao, Goa. Its website is agrawalgroupgoa.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressAnand Bhavan Old Station Road, Margao, Goa, India – 403601
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Agrawal Medicaments Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Agrawal Medicaments is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Agrawal Medicaments Private Limited, buy the company report.
Financials of Agrawal Medicaments Private Limited
FY 2025 filings availableAgrawal Medicaments Private Limited reported revenue of ₹16.64 Lakh (down 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 29% over five years, including a 28% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -71.6% | ||||
| Net Profit Margin | -71.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Agrawal Medicaments Private Limited, buy the company report.
Board of directors of Agrawal Medicaments Private Limited
Agrawal Medicaments has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnakumar Gangadhar Agrawal Also directs: Agrawal Minerals (Goa) Private Limited, Aryavaan Pharmaceuticals Private Limited, Dci Pharmaceuticals Private Limited and 5 more | Director | 07 Dec 2012 | 13 Years 10 Months | Current |
| Anirudh Krishnakumar Agrawal Also directs: Agrawal Minerals (Goa) Private Limited, Aryavaan Pharmaceuticals Private Limited, Dci Pharmaceuticals Private Limited and 5 more | Director | 07 Dec 2012 | 13 Years 10 Months | Current |
| Anurag Agrawal Also directs: Agrawal Minerals (Goa) Private Limited, Aryavaan Pharmaceuticals Private Limited, Dci Pharmaceuticals Private Limited and 5 more | Director | 07 Dec 2012 | 13 Years 10 Months | Current |
Auditor
Agrawal Medicaments Private Limited is audited by H K APARANJI for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H K APARANJI | FY 2015 | 000199S |
Shareholding
The shareholding of Agrawal Medicaments Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Agrawal Medicaments Private Limited, buy the company report.
Legal cases
Agrawal Medicaments Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Krishna, Andhra Pradesh | Civil suit | Filed against the company by M/S. Sri. Lakshmi Medical Stores Rep by Its Prop. K.Rama Chandra Rao | Disposed |
To see the full case history of Agrawal Medicaments Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Agrawal Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Agrawal Medicaments Private Limited has a workforce of 1 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Agrawal Medicaments has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AALCA7314F1Z3 | Goa | Active | 01 Jul 2017 |
| 27AALCA7314F1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Agrawal Medicaments Private Limited, buy the company report.
Recent activity
Agrawal Medicaments Private Limited has 3 board changes on record since 2012: 3 appointments. The latest: Anirudh Krishnakumar Agrawal was appointed as Director on 07 Dec 2012.
Frequently asked questions
Agrawal Medicaments is an active private limited company based in Margao, Goa, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 December 2012 (14+ years old) and is registered under CIN U24119GA2012PTC007117.
Agrawal Medicaments has 3 current directors:
- Krishnakumar Gangadhar Agrawal - Director
- Anirudh Krishnakumar Agrawal - Director
- Anurag Agrawal - Director
The latest financial statements of Agrawal Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Agrawal Medicaments is 30AALCA7314F1Z3, registered in Goa. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AALCA7314F1ZQ (Maharashtra).
The CIN (Corporate Identification Number) of Agrawal Medicaments is U24119GA2012PTC007117. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Agrawal Medicaments has 1 court case on record: 1 filed against it.
Agrawal Medicaments was incorporated on 07 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Goa.
Anirudh Krishnakumar Agrawal was appointed as Director on 07 Dec 2012. Anurag Agrawal was appointed as Director on 07 Dec 2012. Krishnakumar Gangadhar Agrawal was appointed as Director on 07 Dec 2012.
Agrawal Medicaments can be reached through the website agrawalgroupgoa.com. Its registered office is in Margao, Goa, India.
The registered office of Agrawal Medicaments is at Anand Bhavan Old Station Road, Margao, Goa, India – 403601.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
